FDA Places Clinical Hold on Aardvark Therapeutics' IND, Company to Unblind Data
The FDA has issued a full clinical hold on Aardvark Therapeutics' investigational new drug application. In response, Aardvark Therapeutics plans to unblind data from its HERO and OLE studies to…








